Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-053956
Filing Date
2010-03-11
Accepted
2010-03-11 17:07:43
Documents
13
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1114010
2 AMENDED AND RESTATED LICENSE AGREEMENT dex105.htm EX-10.5 182796
3 SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT - MILIND DESPHANDE dex1010.htm EX-10.10 47433
4 SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT - MARY KAY FENTON dex1012.htm EX-10.12 47431
5 2006 STOCK INCENTIVE PLAN AS AMENDED SEPTEMBER 18, 2006 AND MARCH 9, 2010 dex1026.htm EX-10.26 59141
6 2006 EMPLOYEE STOCK PURCHASE PLAN AS AMENDED SEPTEMBER 18, 2006 dex1032.htm EX-10.32 38525
7 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1495
8 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9526
9 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9524
10 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 3250
11 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 3222
12 GRAPHIC g26556g25n97.jpg GRAPHIC 27098
13 GRAPHIC g26556g37z70.jpg GRAPHIC 70111
  Complete submission text file 0001193125-10-053956.txt   1651917
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33095 | Film No.: 10674771
SIC: 2834 Pharmaceutical Preparations